Folotyn (pralatrexate injection) for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma: U.S. Food and Drug Administration drug approval summary.
Clin Cancer Res
; 16(20): 4921-7, 2010 Oct 15.
Article
in En
| MEDLINE
| ID: mdl-20739433
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lymphoma, T-Cell
/
Aminopterin
Type of study:
Clinical_trials
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
America do norte
Language:
En
Journal:
Clin Cancer Res
Journal subject:
NEOPLASIAS
Year:
2010
Document type:
Article
Affiliation country:
United States